Introduction
Photon counting CT improves spatial resolution and contrast to noise ratio which enhances detection of small pulmonary nodules. Spectral information helps differentiate calcified from non calcified nodules and characterize tissue composition. These capabilities support earlier detection and more confident characterization.
ILD and Fibrosis
High resolution spectral imaging improves visualization of fine reticular patterns and traction bronchiectasis. Quantitative metrics derived from spectral data may correlate with physiologic impairment and disease progression. Standardized acquisition and longitudinal consistency are important for monitoring.
Nodule Management
Improved conspicuity and reduced noise support more accurate volumetric measurements for nodule surveillance. Spectral reconstructions can aid in differentiating benign from malignant features and guide management decisions. Integration with nodule tracking software enhances follow up workflows.
Operational Considerations
Adoption requires protocol optimization and radiologist training in spectral interpretation and artifact recognition. Cost and throughput implications should be evaluated against clinical benefits for lung screening and ILD programs. Multicenter studies will clarify impact on outcomes and screening performance.